Abstract

N-alkylated amino acids occur widely in nature and can also be found in bioactive secondary metabolites such as the glycopeptide antibiotic vancomycin and the immunosuppressant cyclosporine A. To meet the demand for N-alkylated amino acids, they are currently produced chemically; however, these approaches often lack enantiopurity, show low product yields and require toxic reagents. Fermentative routes to N-alkylated amino acids like N-methyl-l-alanine or N-methylantranilate, a precursor of acridone alkaloids, have been established using engineered Corynebacterium glutamicum, which has been used for the industrial production of amino acids for decades. Here, we describe metabolic engineering of C. glutamicum for de novo production of N-methylphenylalanine based on reductive methylamination of phenylpyruvate. Pseudomonas putida Δ-1-piperideine-2-carboxylate reductase DpkA containing the amino acid exchanges P262A and M141L showed comparable catalytic efficiencies with phenylpyruvate and pyruvate, whereas the wild-type enzyme preferred the latter substrate over the former. Deletion of the anthranilate synthase genes trpEG and of the genes encoding branched-chain amino acid aminotransferase IlvE and phenylalanine aminotransferase AroT in a strain engineered to overproduce anthranilate abolished biosynthesis of l-tryptophan and l-phenylalanine to accumulate phenylpyruvate. Upon heterologous expression of DpkAP262A,M141L, N-methylphenylalanine production resulted upon addition of monomethylamine to the medium. In glucose-based minimal medium, an N-methylphenylalanine titer of 0.73 ± 0.05 g L−1, a volumetric productivity of 0.01 g L−1 h−1 and a yield of 0.052 g g−1 glucose were reached. When xylose isomerase gene xylA from Xanthomonas campestris and the endogenous xylulokinase gene xylB were expressed in addition, xylose as sole carbon source supported production of N-methylphenylalanine to a titer of 0.6 ± 0.04 g L−1 with a volumetric productivity of 0.008 g L−1 h−1 and a yield of 0.05 g g−1 xylose. Thus, a fermentative route to sustainable production of N-methylphenylalanine by recombinant C. glutamicum has been established.

Highlights

  • N-methylated amino acids are found in bacteria and eukaryotes

  • E. coli DH5α was used for plasmid construction and was cultivated in lysogeny broth (LB)

  • To ease accommodation of the larger phenyl substituent in the substrate binding pocket, the prolyl residue 262 and the methioninyl residue 141 were replaced by alanyl and leucyl residues, respectively, in DpkA P262A,M141L

Read more

Summary

Introduction

N-methylated amino acids are found in bacteria and eukaryotes These non- proteinogenic amino acids occur in peptides or as free monomers. F117L ) proved valuable to produce sarcosine and N-ethyl-glycine [29]. ) proved to produce sarcosine and N-ethyl-glycine. 2-oxoacid substrates differ by relative activity with phenylpyruvate and pyruvate. The two 2-oxoacid substrates differ by the size of their substituents: a small methyl group in pyruvate as compared to the large phenyl group of phenylpyruvate. To ease accommodation of the larger phenyl substituent in the substrate binding pocket, the prolyl residue 262 and the methioninyl residue 141 were replaced by alanyl and leucyl residues, respectively, in DpkA P262A,M141L

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.